Profound Medical Income Statement (2023-2025) | PROF

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.86M1.60M1.73M2.01M1.44M2.23M2.83M4.18M2.62M2.21M5.29M
Cost of Revenue 0.65M0.55M0.67M1.02M0.57M0.81M1.04M1.21M0.77M0.59M1.36M
Gross Profit 1.21M1.05M1.06M0.99M0.87M1.42M1.79M2.96M1.85M1.62M3.93M
Operating items
Amortization - Intangibles 0.05M0.05M0.05M0.05M0.05M0.05M
Research & Development 3.84M3.15M3.42M4.01M3.94M4.21M4.17M4.65M4.81M6.10M5.42M
Share-based Compensation (IS) 0.94M0.84M0.73M0.94M0.84M0.36M
Selling, General & Administrative 2.11M2.08M2.02M12.33M4.80M5.06M6.62M6.66M8.21M9.33M7.43M
Other Operating Expenses 2.10M2.25M2.18M-6.54M
Operating Expenses 8.05M7.49M7.62M9.81M8.74M9.26M10.79M11.31M13.02M15.42M12.84M
Operating Income 6.84M6.44M6.56M-48.48M-7.88M-7.84M-9.00M-8.35M-11.17M-13.81M-8.91M
EBIT 6.84M6.44M6.56M-48.48M-7.88M-7.84M-9.00M-8.35M-11.17M-13.81M-8.91M
Non-operating items
Interest & Investment Income 0.46M0.42M0.22M0.33M0.45M0.34M0.12M
Other Non Operating Income 0.05M4.12M-3.92M-0.82M0.87M0.52M-0.41M2.83M0.04M-2.17M0.94M
Non Operating Income 0.14M0.88M-1.01M-0.07M1.33M0.94M-0.19M3.16M0.48M-1.82M1.06M
Net income details
EBT 6.69M7.32M5.55M-48.91M-6.54M-6.90M-9.19M-5.65M-10.68M-15.63M-7.86M
Tax Provisions 0.05M0.04M0.02M-0.29M0.04M0.02M0.18M-0.09M0.04M0.08M0.12M
Profit After Tax 6.74M7.36M5.56M-47.98M-6.58M-6.92M-9.37M-4.95M-10.72M-15.70M-7.98M
Income from Continuing Operations 6.64M7.29M5.53M-48.62M-6.58M-6.92M-9.37M-5.56M-10.72M-15.71M-7.98M
Consolidated Net Income 6.64M7.29M5.53M-48.62M-6.58M-6.92M-9.37M-5.56M-10.72M-15.71M-7.98M
Income towards Parent Company 6.64M7.29M5.53M-48.62M-6.58M-6.92M-9.37M-5.56M-10.72M-15.71M-7.98M
Net Income towards Common Stockholders 6.64M7.29M5.53M-48.62M-6.58M-6.92M-9.37M-5.56M-10.72M-15.70M-7.98M
Additional items
EPS (Basic) -2.30-3.25-3.42-0.220.360.520.26
EPS (Weighted Average and Diluted) -2.300.270.280.38-0.220.360.520.26
Shares Outstanding (Weighted Average) 21.18M2.02M2.02M24.77M30.04M30.06M30.12M
Shares Outstanding (Diluted Average) 21.18M24.77M30.04M30.06M30.12M
EBITDA 6.84M6.44M6.56M-48.48M-7.55M-7.39M-8.78M-6.92M-10.62M-12.98M-8.79M
Interest Expenses 0.19M0.19M0.20M0.18M0.18M0.13M
Tax Rate 0.72%0.48%0.32%0.59%-0.61%-0.28%-1.93%1.63%-0.38%-0.50%-1.54%